Ophthalmic Research Associate is categorized under Medical Labs in North Andover, MA and active since 2011.
Ophthalmic Research Associate was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Catherine Hodges at the company’s single location by writing to 863 Turnpike St, North Andover, Massachusetts MA 01845 or by phoning (978) 685-8900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Ophthalmic Research Associate |
Contact Person: | Catherine Hodges |
Address: | 863 Turnpike St, North Andover, Massachusetts 01845 |
Phone Number: | (978) 685-8900 |
Website Address: | oraclinical.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Medical Labs |
SIC Code: | 8071 |
NAICS Code: | 621511 |
Share This Business: |
Ophthalmic Research Associate was started in 2011 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Catherine Hodges for inquiries that concern Ophthalmic Research Associate by calling the company number (978) 685-8900, as your correspondence is most welcome. Additionally, the physical location of the single location of Ophthalmic Research Associate can be found at the coordinates 42.657953,-71.105161 as well as the street address 863 Turnpike St in North Andover, Massachusetts 01845.
For its online presence, you may visit Ophthalmic Research Associate’s website at oraclinical.com and engage with its social media outlets through on Twitter and on Facebook.